Aridis Pharmaceuticals Inc (ARDS) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aridis Pharmaceuticals Inc   (NASDAQ: ARDS)


Aridis Pharmaceuticals Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aridis Pharmaceuticals Inc's ROI in the third quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Aridis Pharmaceuticals Inc 's return on investment (ROI) in its third quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -11 -14 -26 -22 -30
Return On Investment (TTM) - - - - -
ARDS's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -1 -9 -29 -30 -29

ARDS Company Profile >> Back to ARDS Roi Comparisons >> See Annual ARDS Return On Investment



Return On Investment ARDS's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Aridis Pharmaceuticals Inc's III. Quarter Investments $ -11 Millions ARDS's Balance sheet
Aridis Pharmaceuticals Inc's III. Quarter Income $ 0 Millions Quarterly ARDS's Income Statement
ARDS's Income by Division See ARDS's Income by Division


ARDS Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2017)
2018
Total Investments in Millions -22 -7 -7 9 11
Y / Y Investment Growth - - - -24.48 % -
Net Income in Millions -30 -42 -22 -30 -25
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - -343.69 % -215.6 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ARDS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ARDS's Competitors
Subscribers only: Roi for Aridis Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ARDS's Customers

Other Ratios
ARDS's Roa ARDS's Inventory Turnover Ratio ARDS's Growth Rates ARDS's Dividend Statistics
ARDS's Profitability Ratios ARDS's Asset Turnover Ratio ARDS's Dividend Growth
ARDS's Roe ARDS's Valuation Ratios ARDS's Financial Strength Ratios ARDS's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI
Exicure Inc   17.03 %
Agilent Technologies inc   16.70 %
Resmed Inc   15.61 %
International Stem Cell Corporation  15.54 %
Earth Science Tech Inc   15.52 %
Waters Corporation  15.33 %
Regeneron Pharmaceuticals Inc   15.08 %
Halozyme Therapeutics Inc   15.07 %
Eli Lilly And Company  14.86 %
United Therapeutics Corporation  14.80 %
Hca Healthcare Inc   14.58 %
Amphastar Pharmaceuticals Inc   14.51 %
Zynex inc   14.03 %
Alpha Pro Tech Ltd   13.87 %
Utah Medical Products Inc  13.77 %
Bruker Corporation  13.62 %
Alkermes Plc   13.48 %
Carlisle Companies Incorporated  12.90 %
Bristol myers Squibb Company  12.65 %
Intuitive Surgical Inc   12.60 %
Ufp Technologies Inc   12.38 %
Orasure Technologies Inc  12.11 %
Gilead Sciences Inc   11.83 %
Amgen Inc   11.61 %
Eton Pharmaceuticals Inc   11.52 %
Progyny Inc   11.26 %
Revelation Biosciences Inc   11.18 %
Patterson Companies Inc   10.87 %
Cadre Holdings inc   10.86 %
Bio techne Corp  10.39 %

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.